BPC-157 + TB-500 + GHK-Cu
Research blend studied for tissue remodeling pathways, collagen synthesis mechanisms, and regenerative models in laboratory settings.
Shipped in an insulated package with ice pack to maintain product integrity during transit.
More Info:
GHK-Cu component
• Sequence: Gly-His-Lys · Cu²⁺
• Formula (complex): C₁₄H₂₂CuN₆O₄ (approx.)
• MW: ≈ 402–404 Da
BPC-157 component
• Sequence: GEPPPGKPADDAGLV (15 aa)
• Formula: C₆₂H₉₈N₁₆O₂₂
• MW: ≈ 1419.5 Da
TB-500 / Thymosin β4 fragment
• Core active region typically Ac-SDKP or longer TB-500 sequence (43 aa fragment of thymosin β4).
• MW of common research TB-500: ≈ 4963 Da (full fragment varies by supplier lot).
Framing for blend vials: Multi-component lyophilized research blend combining the copper-coordinated tripeptide GHK-Cu with the pentadecapeptide BPC-157 and TB-500 fragment. Designed for controlled in-vitro or model-system studies of tissue-matrix and regenerative signaling pathways. Exact ratios (e.g., 50 mg GHK-Cu / 10 mg BPC / 10 mg TB or Klow variant with KPV)
BPC-157 + TB-500 + GHK-Cu
Research blend studied for tissue remodeling pathways, collagen synthesis mechanisms, and regenerative models in laboratory settings.
Shipped in an insulated package with ice pack to maintain product integrity during transit.
More Info:
GHK-Cu component
• Sequence: Gly-His-Lys · Cu²⁺
• Formula (complex): C₁₄H₂₂CuN₆O₄ (approx.)
• MW: ≈ 402–404 Da
BPC-157 component
• Sequence: GEPPPGKPADDAGLV (15 aa)
• Formula: C₆₂H₉₈N₁₆O₂₂
• MW: ≈ 1419.5 Da
TB-500 / Thymosin β4 fragment
• Core active region typically Ac-SDKP or longer TB-500 sequence (43 aa fragment of thymosin β4).
• MW of common research TB-500: ≈ 4963 Da (full fragment varies by supplier lot).
Framing for blend vials: Multi-component lyophilized research blend combining the copper-coordinated tripeptide GHK-Cu with the pentadecapeptide BPC-157 and TB-500 fragment. Designed for controlled in-vitro or model-system studies of tissue-matrix and regenerative signaling pathways. Exact ratios (e.g., 50 mg GHK-Cu / 10 mg BPC / 10 mg TB or Klow variant with KPV)
